Article Details
Retrieved on: 2022-06-09 15:23:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
IGC recently completed the first Phase 1 safety and tolerability clinical trial for patients suffering from Alzheimer's disease using a THC-based ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here